As of 2025-01-13, the Relative Valuation of BioLife Solutions Inc (BLFS) is (17.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.61 USD, the upside of BioLife Solutions Inc based on Relative Valuation is -166.1%.
The range of the Relative Valuation is (15.56) - (15.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 23.8x | 19.7x |
| Forward P/E multiples | 15.5x - 15.6x | 15.6x |
| Fair Price | (15.56) - (15.56) | (17.58) |
| Upside | -158.5% - -158.5% | -166.1% |
| Date | P/E |
| 2025-01-08 | -27.76 |
| 2025-01-07 | -27.18 |
| 2025-01-06 | -27.33 |
| 2025-01-03 | -26.49 |
| 2025-01-02 | -26.25 |
| 2024-12-31 | -26.02 |
| 2024-12-30 | -26.34 |
| 2024-12-27 | -26.66 |
| 2024-12-26 | -27.10 |
| 2024-12-24 | -26.57 |
| 2024-12-23 | -26.45 |
| 2024-12-20 | -27.46 |
| 2024-12-19 | -26.18 |
| 2024-12-18 | -25.04 |
| 2024-12-17 | -26.94 |
| 2024-12-16 | -27.44 |
| 2024-12-13 | -26.77 |
| 2024-12-12 | -26.79 |
| 2024-12-11 | -26.39 |
| 2024-12-10 | -26.27 |
| 2024-12-09 | -26.34 |
| 2024-12-06 | -26.31 |
| 2024-12-05 | -25.24 |
| 2024-12-04 | -26.45 |
| 2024-12-03 | -26.88 |
| 2024-12-02 | -27.34 |
| 2024-11-29 | -27.54 |
| 2024-11-27 | -27.23 |
| 2024-11-26 | -27.13 |
| 2024-11-25 | -26.84 |
| 2024-11-22 | -26.07 |
| 2024-11-21 | -25.45 |
| 2024-11-20 | -25.07 |
| 2024-11-19 | -22.50 |
| 2024-11-18 | -20.52 |
| 2024-11-15 | -21.07 |
| 2024-11-14 | -21.70 |
| 2024-11-13 | -24.17 |
| 2024-11-12 | -26.57 |
| 2024-11-11 | -26.67 |
| 2024-11-08 | -26.20 |
| 2024-11-07 | -26.21 |
| 2024-11-06 | -26.67 |
| 2024-11-05 | -25.98 |
| 2024-11-04 | -25.62 |
| 2024-11-01 | -24.13 |
| 2024-10-31 | -23.46 |
| 2024-10-30 | -24.12 |
| 2024-10-29 | -23.65 |
| 2024-10-28 | -22.92 |